484
Views
16
CrossRef citations to date
0
Altmetric
Invited Review

The diagnosis and management of contact lens‐related microbial keratitis

, BOptom (Hons) PhD FAAO FBCLA, , BSci (Med) MBBS PhD FRANZCO, , BMedSci (Hons) MBBS PhD FRANZCO & , PhD BSc (Hons) (Optometry) MCOptom FAAO FBCLA
Pages 482-493 | Received 30 Mar 2017, Accepted 27 May 2017, Published online: 15 Apr 2021

REFERENCES

  • Stapleton F, Keay L, Edwards K et al. The incidence of contact lens‐related microbial keratitis in Australia. Ophthalmology 2008; 115: 1655–1662.
  • Poggio EC, Glynn RJ, Schein OD et al. The incidence of ulcerative keratitis among users of daily‐wear and extended‐wear soft contact lenses. N Engl J Med 1989; 321: 779–783.
  • Lam DSC, Houang E, Fan DSP et al. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye 2002; 16: 608–618.
  • Cheng K, Leung D, Hoekman H et al. Incidence of contact‐lens‐associated microbial keratitis and its related morbidity. Lancet 1999; 354: 181–184.
  • Seal D, Kirkness C, Bennett H et al. Population‐based cohort study of microbial keratitis in Scotland: Incidence and features. Contact Lens and Anterior Eye 1999; 22: 49–57.
  • Papas E, Vajdic CM, Austen R et al. High oxygen transmissibility soft contact lenses do not induce limbal hyperaemia. Curr Eye Res 1997; 16: 942–948.
  • Dart JKG, Radford CF, Minassian D et al. Risk factors for microbial keratitis with contemporary contact lenses: a case–control study. Ophthalmology 2008; 115: 1647–1654.e1643.
  • Chalmers RL, Keay L, Mcnally J et al. Multicenter case–control study of the role of lens materials and care products on the development of corneal infiltrates. Optom Vis Sci 2012; 89: 316–325.
  • Richdale K, Lam DY, Wagner H et al. Case–control pilot study of soft contact lens wearers with corneal infiltrative events and healthy controls. Invest Ophthalmol Vis Sci 2016; 57: 47–55.
  • Watt K, Swarbrick HA. Microbial keratitis in overnight orthokeratology: Review of the first 50 cases. Eye & Contact Lens 2005; 31: 201–208.
  • Steinemann TL, Pinninti U, Szczotka LB et al. Ocular complications associated with the use of cosmetic contact lenses from unlicensed vendors. Eye & Contact Lens 2003; 29: 196–200.
  • Tran T, Samarawickrama C, Petsoglou C et al. Recent cluster of childhood microbial keratitis due to orthokeratology. Clin Exp Ophthalmol 2014; 42: 793–794.
  • Bullimore MA, Sinnott LT, Jones‐jordan LA. The risk of microbial keratitis with overnight corneal reshaping lenses. Optom Vis Sci 2013; 90: 937–944.
  • Sauer A, Bourcier T, French Study Group for Contact Lenses Related Microbial K. Microbial keratitis as a foreseeable complication of cosmetic contact lenses: a prospective study. Acta Ophthalmol 2011; 89: e439–442.
  • Allan BD, Dart JK. Strategies for the management of microbial keratitis. Br J Ophthalmol 1995; 79: 777–786.
  • Gower EW, Keay LJ, Oechsler RA et al. Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology 2010; 117: 2263–2267.
  • Verani JR, Lorick SA, Yoder JS et al. National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis 2009; 15: 1236–1242.
  • Yoder JS, Verani J, Heidman N et al. Acanthamoeba keratitis: the persistence of cases following a multistate outbreak. Ophthalmic Epidemiol 2012; 19: 221–225.
  • Jasim H, Knox‐cartwright N, Cook S et al. Increase in acanthamoeba keratitis may be associated with use of multipurpose contact lens solution. BMJ 2012; 344: e1246.
  • Chawla A, Armstrong M, Carley F. Acanthamoeba keratitis ‐ an increasing incidence. Contact Lens Anterior Eye 2014; 37: 120.
  • Carnt N, Stapleton F. Strategies for the prevention of contact lens‐related Acanthamoeba keratitis: a review. Ophthalmic Physiol Opt 2016; 36: 77–92.
  • Iyer SA, Tuli SS, Wagoner RC. Fungal keratitis: emerging trends and treatment outcomes. Eye & Contact Lens 2006; 32: 267–271.
  • Ong HS, Fung SS, Macleod D et al. Altered patterns of fungal keratitis at a London ophthalmic referral hospital: an eight‐year retrospective observational study. Am J Ophthalmol 2016; 168: 227–236.
  • Keay L, Edwards K, Naduvilath T et al. Factors affecting the morbidity of contact lens related microbial keratitis: a population study. Invest Ophthalmol Visual Sci 2006; 47: 4302–4308.
  • Tuft SJ, Tullo AB. Fungal keratitis in the United Kingdom 2003–2005. Eye (Lond) 2009; 23: 1308–1313.
  • Willcox MD. Which is more important to the initiation of contact lens related microbial keratitis, trauma to the ocular surface or bacterial pathogenic factors? Clin Exp Optom 2006; 89: 277–279.
  • Sankaridurg PR, Sharma S, Willcox M et al. Bacterial colonization of disposable soft contact lenses is greater during corneal infiltrative events than during asymptomatic extended lens wear. J Clin Microbiol 2000; 38: 4420–4424.
  • Soumpasis I, Knapp L, Pitt T. A proof‐of‐concept model for the identification of the key events in the infection process with specific reference to Pseudomonas aeruginosa in corneal infections. Infect Ecol Epidemiol 2015; 5: 28750.
  • Willcox MD, Power KN, Stapleton F et al. Potential sources of bacteria that are isolated from contact lenses during wear. Optom Vis Sci 1997; 74: 1030–1038.
  • Choo J, Vuu K, Bergenske P et al. Bacterial populations on silicone hydrogel and hydrogel contact lenses after swimming in a chlorinated pool. Optom Vis Sci 2005; 82: 134–137.
  • Wu YT, Tran J, Truong M et al. Do swimming goggles limit microbial contamination of contact lenses? Optom Vis Sci 2011; 88: 456–460.
  • Willcox MDP, Naduvilath TJ, Vaddavalli PK et al. Corneal erosions, bacterial contamination of contact lenses, and microbial keratitis. Eye & Contact Lens: Sci Clin Pract 2010; 36: 340–345.
  • Willcox MDP, Carnt N, Diec J et al. Contact lens case contamination during daily wear of silicone hydrogels. Optom Vis Sci 2010; 87: 456–464.
  • Larkin DFP, Leeming JP. Quantitative alterations of the commensal eye bacteria in contact lens wear. Eye 1991; 5: 70–74.
  • Hovding G. The conjunctival and contact lens bacterial flora during lens wear. Acta Ophthalmol (Copenh) 1981; 59: 387–401.
  • Melia B, Islam T, Madgula I et al. Contact lens referrals to Hull Royal Infirmary Ophthalmic A&E Unit. Contact Lens Anterior Eye 2008; 31: 195–199.
  • Morgan PB, Efron N, Raynor MK et al. Incidence of keratitis of varying severity among contact lens wearers. Br J Ophthalmol 2005; 89: 430–436.
  • Fleiszig SMJ. The pathogenesis of contact lens related microbial keratitis. Optom Vis Sci 2005; 83: 866–873.
  • Gorski M, Genis A, Yushvayev S et al. Seasonal variation in the presentation of infectious keratitis. Eye & Contact Lens 2016; 42: 295–297.
  • Edwards K, Keay L, Naduvilath T et al. Characteristics of and risk factors for contact lens‐related microbial keratitis in a tertiary referral hospital. Eye 2009; 23: 153–160.
  • Bourcier T, Thomas F, Borderie V et al. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 2003; 87: 834–839.
  • Gray LD, Gilligan PH, Fowler WC. Cumitech 13B, Laboratory Diagnosis of Ocular Infections. Washington, DC.: ASM Press 2011.
  • Kaye R, Kaye A, Sueke H et al. Recurrent bacterial keratitis. Invest Ophthalmol Vis Sci 2013; 54: 4136–4139.
  • Kheir WJ, Sheheitli H, Abdul fattah M et al. Nontuberculous mycobacterial ocular infections: a systematic review of the literature. BioMed Res Internat 2015; 2015: 164989.
  • Wiley L, Bridge DR, Wiley LA et al. Bacterial biofilm diversity in contact lens‐related disease: emerging role of Achromobacter, Stenotrophomonas, and Delftia. Invest Ophthalmol Vis Sci 2012; 53: 3896–3905.
  • Kodjikian L, Casoli‐bergeron E, Malet F et al. Bacterial adhesion to conventional hydrogel and new silicone‐hydrogel contact lens materials. Graefes Arch Clin Exp Ophthalmol 2008; 246: 267–273.
  • Willcox MD, Harmis N, Cowell et al. Bacterial interactions with contact lenses; effects of lens material, lens wear and microbial physiology. Biomaterials 2001; 22: 3235–3247.
  • Szczotka‐flynn L, Lass JH, Sethi A et al. Risk factors for corneal infiltrative events during continuous wear of silicone hydrogel contact lenses. Invest Ophthalmol Vis Sci 2010; 51: 5421–5430.
  • Mclaughlin‐borlace L, Stapleton F, Matheson M et al. Bacterial biofilm on contact lenses and lens storage cases in wearers with microbial keratitis. J Appl Microbiol 1998; 84: 827–838.
  • Liu LY, Seo J, Mccanna DJ et al. Assessment of biofilm formation of E. meningoseptica, D. acidovorans, and S. maltophilia in lens cases and their growth on recovery media. Contact Lens Anterior Eye 2016; 39: 117–123.
  • Zantos SG. Corneal infiltrates, debris, and microcysts. J Am Optom Assoc 1984; 55: 196–199.
  • Nilsson SEG, Montan PG. The annualized incidence of contact lens induced keratitis in Sweden and its relation to lens type and wear schedule: results of a 3‐month prospective study. Contact Lenses Assoc Ophthalmol J 1994; 20: 225–230.
  • Stapleton F, Dart JKG, Minassian D. Risk factors in contact lens related suppurative keratitis. CLAO J 1993; 19: 204–210.
  • Dart JKG, Stapleton F, Minassian D. Contact lenses and other risk factors in microbial keratitis. Lancet 1991; 338: 650–654.
  • Ladage PM, Ren DH, Petroll WM et al. Effects of eyelid closure and disposable and silicone hydrogel extended contact lens wear on rabbit corneal epithelial cell proliferation. Invest Ophthalmol Visual Sci 2003; 44: 1843–1849.
  • Ladage PM, Jester JV, Petroll WM et al. Vertical movement of epithelial basal cells towards the corneal surface during use of extended wear contact lenses. Invest Ophthalmol Vis Sci 2003; 44: 1056–1063.
  • O'leary DJ, Madgewick R, Wallace J et al. Size and number of epithelial cells washed from the cornea after contact lens wear. Optom Vis Sci 1998; 75: 692–696.
  • Ren H, Petroll WM, Jester JV et al. The relationship between contact lens oxygen permeability and binding of Pseudomonas aeruginosa to human corneal epithelial cells in overnight and extended wear. CLAO J 1999; 25: 80–100.
  • Ladage PM, Yamamoto K, Ren DH et al. Effects of rigid and soft contact lens daily wear on corneal epithelium, tear lactate dehydrogenase, and bacterial binding to exfoliated cells. Ophthalmology 2001; 108: 1279–1288.
  • Lin MC, Polse KA. Hypoxia, overnight wear, and tear stagnation effects on the corneal epithelium: data and proposed model. Eye & Contact Lens 2007; 33: 378–381.
  • Lin MC, French HM, Graham AD et al. Effects of daily irrigation on corneal epithelial permeability and adverse events with silicone hydrogel contact lens continuous wear. Invest Ophthalmol Vis Sci 2014; 55: 776–783.
  • Keay L, Stapleton F. Development and evaluation of evidence‐based guidelines on contact lens‐related microbial keratitis. Contact Lens Anterior Eye 2008; 31: 3–12.
  • Radford CF, Lehmann OJ, Dart JK. Acanthamoeba keratitis: multicentre survey in England 1992–6. National Acanthamoeba Keratitis Study Group. Brit J Ophthalmol 1998; 82: 1387–1392.
  • Radford CF, Minassian D, Dart JKG. Acanthamoeba keratitis in England and Wales: incidence, outcome and risk factors. Br J Ophthalmol 2002; 86: 536–542.
  • Seal D, Kirkness C, Bennett H et al. Acanthamoeba keratitis in Scotland: Risk factors for contact lens wearers. Contact Lens Anterior Eye 1999; 22: 58–68.
  • Schein OD, Glynn RJ, Poggio EC et al. The relative risk of ulcerative keratitis among users of daily‐wear and extended‐wear soft contact lenses. N Engl J Med 1989; 321: 773–778.
  • Efron N, Wohl A, Toma NG et al. Pseudomonas corneal ulcers associated with daily wear of disposable hydrogel contact lenses. Internat Contact Lens Clinic 1991; 18: 46–51.
  • Stapleton F, Dart JKG, Seal DV et al. Epidemiology of Pseudomonas aeruginosa keratitis in contact lens wearers. Epidemiol Infect 1995; 114: 395–402.
  • Radford CF, Minassian DC, Dart JKG. Disposable contact lens use as a risk factor for microbial keratitis. Br J Ophthalmol 1998; 82: 1272–1275.
  • Morgan PB, Efron N, Brennan NA et al. Risk factors for the development of corneal infiltrative events associated with contact lens wear. Invest Ophthalmol Vis Sci 2005; 46: 3136–3143.
  • Chang DC, Grant GB, O'donnell K et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 2006; 296: 953–963.
  • Saw S‐M, Ooi P‐L, Tan DTH et al. Risk factors for contact lens‐related fusarium keratitis: a case–control study in Singapore. Arch Ophthalmol 2007; 125: 611–617.
  • Joslin CE, Tu EY, Shoff ME et al. The association of contact lens solution use and Acanthamoeba keratitis.[see comment]. Am J Ophthalmol 2007; 144: 169–180.
  • Keijser S, Kurreeman FA, de Keizer RJ et al. IL‐10 promotor haplotypes associated with susceptibility to and severity of bacterial corneal ulcers. Exp Eye Res 2009; 88: 1124–1128.
  • Carnt NA, Willcox MD, Hau S et al. Association of single nucleotide polymorphisms of interleukins‐1beta, −6, and ‐12B with contact lens keratitis susceptibility and severity. Ophthalmology 2012; 119: 1320–1327.
  • Carnt NA, Willcox MD, Hau S et al. Immune defense single nucleotide polymorphisms and recruitment strategies associated with contact lens keratitis. Ophthalmology 2012; 119: 1997–2002.
  • Lim CH, Carnt NA, Farook M et al. Risk factors for contact lens‐related microbial keratitis in Singapore. Eye (Lond) 2016; 30: 447–455.
  • Brown AC, Ross J, Jones DB et al. Risk factors for Acanthamoeba keratitis: a multistate case–control study, 2008–2011. Eye Contact Lens 2017; http://dx.doi.org/10.1097/ICL.0000000000000365
  • Phillips SP. Defining and measuring gender: a social determinant of health whose time has come. Int J Equity Health 2005; 4: 11.
  • Brett KM, Burt CW. Utilization of ambulatory medical care by women: United States, 1997–98. Vital Health Stat 13 2001; 149: 1–46.
  • The impact of topical corticosteroids used in conjunction with antiamoebic therapy on the outcome of Acanthamoeba keratitis. Ophthalmology 2016; 123: 984–990.
  • Carnt N, Keay L, Willcox M et al. Higher risk taking propensity of contact lens wearers is associated with less compliance. Contact Lens Anterior Eye 2011; 34: 202–206.
  • Willcox M. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci 2007; 84: 273–278.
  • Oka N, Suzuki T, Ishikawa E et al. Relationship of virulence factors and clinical features in keratitis caused by Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 2015; 56: 6892–6898.
  • Shen EP, Hsieh YT, Chu HS et al. Correlation of Pseudomonas aeruginosa genotype with antibiotic susceptibility and clinical features of induced central keratitis. Invest Ophthalmol Vis Sci 2014; 56: 365–371.
  • Borkar DS, Acharya NR, Leong C et al. Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones. BMC Ophthalmol 2014; 14: 54.
  • Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 2009; 148: 487–499.e2.
  • Robbie SJ, Vega FA, Tint NL et al. Perineural infiltrates in Pseudomonas keratitis. J Cataract Refract Surg 2013; 39: 1764–1767.
  • Robaei D, Carnt N, Minassian DC et al. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis. Ophthalmology 2014; 121: 1383–1388.
  • Abad JC, Foster CS. Fungal keratitis. Int Ophthalmol Clin 1996; 36: 1–15.
  • Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003; 16: 730–797.
  • Loh RS, Chan CM, Ti SE et al. Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management. Ophthalmology 2009; 116: 2348–2353.
  • Lim C, Carnt N, Farook M et al. Risk factors for contact lens related microbial keratitis in Singapore. Eye (Lond) 2016; 30: 447–455.
  • Dahlgren MA, Lingappan A, Wilhelmus KR. The clinical diagnosis of microbial keratitis. Am J Ophthalmol 2007; 143: 940–944.
  • Chang HY, Chodosh J. Diagnostic and therapeutic considerations in fungal keratitis. Int Ophthalmol Clin 2011; 51: 33–42.
  • Thomas PA, Leck AK, Myatt M. Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. Br J Ophthalmol 2005; 89: 1554–1558.
  • Carnt N, Stapleton F. Silicone hydrogel lens‐solution interaction and inflammation. Eye Contact Lens 2013; 39: 37–41.
  • Optometry Board of Australia. Registration data table – December 2016. 2017. [Cited 16 Mar 2017.] Available at: http://www.optometryboard.gov.au/About/Statistics.aspx.
  • Dumbleton K. Noninflammatory silicone hydrogel contact lens complications. Eye Contact Lens 2003; 29: S186–189.
  • Holden BA, Stephenson A, Stretton S et al. Superior epithelial arcuate lesions with soft contact lens wear. Optom Vis Sci 2001; 78: 9–12.
  • O'hare N, Stapleton F, Naduvilath T et al. Interaction between the contact lens and the ocular surface in the etiology of superior epithelial arcuate lesions. Adv Exp Med Biol 2002; 506: 973–980.
  • Sankaridurg PR, Sweeney DF, Sharma S et al. Adverse events with extended wear of disposable hydrogels: results for the first 13 months of lens wear. Ophthalmology 1999; 106: 1671–1680.
  • Sweeney DF, Jalbert I, Covey M et al. Clinical characterisation of corneal infiltrative events observed with soft contact lens wear. Cornea 2003; 22: 435–442.
  • Kaufman HE. Adenovirus advances: new diagnostic and therapeutic options. Curr Opin Ophthalmol 2011; 22: 290–293.
  • Aasuri MK, Venkata N, Kumar VM. Clinical (differential) diagnosis of microbial keratitis (MK) and contact lens induced peripheral ulceration. Eye Contact Lens 2003; 29: S60–S62.
  • Keay L, Edwards K, Stapleton F. Signs, symptoms, and comorbidities in contact lens‐related microbial keratitis. Optom Vis Sci 2009; 86: 803–809.
  • Baum J, Dabezies O. Pathogenesis and treatment of ‘sterile’ midperipheral infiltrates associated with soft contact lens use. Cornea 2000; 19: 777–781.
  • Keay L, Edwards K, Stapleton F. Referral pathways and management of contact lens‐related microbial keratitis in Australia and New Zealand. Clin Exp Ophthalmol 2008; 36: 209–216.
  • Cruzat A, Schrems WA, Schrems‐hoesl LM et al. Contralateral clinically unaffected eyes of patients with unilateral infectious keratitis demonstrate a sympathetic immune response. Invest Ophthalmol Vis Sci 2015; 56: 6612–6620.
  • Kaye S. Herpes simplex keratitis: bilateral effects. Invest Ophthalmol Vis Sci 2015; 56: 4907.
  • Leck A. Taking a corneal scrape and making a diagnosis. Commun Eye Health / Int Centre Eye Health 2009; 22: 42–43.
  • Jain AK, Bansal R, Felcida V et al. Evaluation of impression smear in the diagnosis of fungal keratitis. Indian J Ophthalmol 2007; 55: 33–36.
  • Singh K, Nair A, Kumar A et al. Novel approaches in formulation and drug delivery using contact lenses. J Basic Clin Pharmacol 2011; 2: 87–101.
  • Kaye SB, Rao PG, Smith G et al. Simplifying collection of corneal specimens in cases of suspected bacterial keratitis. J Clin Microbiol 2003; 41: 3192–3197.
  • Kaye S, Sueke H, Romano V et al. Impression membrane for the diagnosis of microbial keratitis. Br J Ophthalmol 2016; 100: 607–610.
  • Hau SC, Dart JK, Vesaluoma M et al. Diagnostic accuracy of microbial keratitis with in vivo scanning laser confocal microscopy. Br J Ophthalmol 2010; 94: 982–987.
  • Brasnu E, Bourcier T, Dupas B et al. In vivo confocal microscopy in fungal keratitis. Br J Ophthalmol 2007; 91: 588–591.
  • Constantinou M, Daniell M, Snibson GR et al. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology 2007; 114: 1622–1629.
  • Gangopadhyay N, Daniell M, Weih L et al. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br J Ophthalmol 2000; 84: 378–384.
  • Miller D. Pharmacological treatment for infectious corneal ulcers. Expert Opin Pharmacother 2013; 14: 543–560.
  • Parmar P, Salman A, Kalavathy CM et al. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. Am J Ophthalmol 2006; 141: 282–286.
  • Mallari PL, Mccarty DJ, Daniell M et al. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol 2001; 131: 131–133.
  • Willcox MD. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Clin Exp Optom 2011; 94: 161–168.
  • Green M, Apel A, Stapleton F. A longitudinal study of trends in keratitis in Australia. Cornea 2008; 27: 33–39.
  • Morita Y, Tomida J, Kawamura Y. Responses of Pseudomonas aeruginosa to antimicrobials. Front Microbiol 2014; 4: 422.
  • Mcelvanney AM. Doxycycline in the management of pseudomonas corneal melting: two case reports and a review of the literature. Eye Contact Lens 2003; 29: 258–261.
  • Gokhale NS. Medical management approach to infectious keratitis. Indian J Ophthalmol 2008; 56: 215–220.
  • Clarke DW, Niederkorn JY. The pathophysiology of Acanthamoeba keratitis. Trends Parasitol 2006; 22: 175–180.
  • Elder MJ, Kilvington S, Dart JKG. A clinicopathological study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994; 35: 1059–1064.
  • Alkharashi M, Lindsley K, Law HA et al. Medical interventions for acanthamoeba keratitis. Cochrane Database Syst Rev 2015; CD010792.
  • Lim N, Goh D, Bunce C et al. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am J Ophthalmol 2008; 145: 130–135.
  • Kilvington S, Hughes R, Byas J et al. Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates. Antimicrob Agents Chemother 2002; 46: 2007–2009.
  • Ng J, Frauenfelder F, Winthrop K. Review and update on the epidemiology, clinical presentation, diagnosis, and treatment of fungal keratitis. Curr Fungal Infect Rep 2013; 7: 293–300.
  • Prajna NV, Krishnan T, Mascarenhas J et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol 2013; 131: 422–429.
  • Zrenner E, Tomaszewski K, Hamlin J et al. Effects of multiple doses of voriconazole on the vision of healthy volunteers: a double‐blind, placebo‐controlled study. Ophthalmic Res 2014; 52: 43–52.
  • Prajna NV, Krishnan T, Rajaraman R et al. Effect of oral voriconazole on fungal keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): a randomized clinical trial. JAMA Ophthalmol 2016; 134: 1365–1372.
  • Rahman MR, Minassian DC, Srinivasan M et al. Trial of chlorhexidine gluconate for fungal corneal ulcers. Ophthalmic Epidemiol 1997; 4: 141–149.
  • Rahman MR, Johnson GJ, Husain R et al. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol 1998; 82: 919–925.
  • Stergiopoulou T, Meletiadis J, Sein T et al. Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus. Antimicrob Agents Chemother 2008; 52: 2196–2204.
  • Srinivasan M, Mascarenhas J, Rajaraman R et al. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol 2012; 130: 143–150.
  • Srinivasan M, Mascarenhas J, Rajaraman R. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. Am J Ophthalmol 2014; 157: 327–333.
  • Sy A, Srinivasan M, Mascarenhas J et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Invest Ophthalmol Vis Sci 2012; 53: 267–272.
  • Ray KJ, Srinivasan M, Mascarenhas J et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmol 2014; 132: 737–741.
  • Srinivasan M, Lalitha P, Mahalakshmi R et al. Corticosteroids for bacterial corneal ulcers. Br J Ophthalmol 2009; 93: 198–202.
  • Blair J, Hodge W, Al‐ghamdi S et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Can J Ophthalmol 2011; 46: 40–45.
  • Carmichael TR, Gelfand Y, Welsh NH. Topical steroids in the treatment of central and paracentral corneal ulcers. Br J Ophthalmol 1990; 74: 528–531.
  • Herretes S, Wang X, Reyes JM. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev 2014; CD005430.
  • Miedziak AI, Miller MR, Rapuano CJ et al. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology 1999; 106: 1166–1170.
  • Carnt N, Robaei D, Watson SL et al. The impact of topical corticosteroids used in conjunction with antiamoebic therapy on the outcome of Acanthamoeba keratitis. Ophthalmology 2016; 123: 984–990.
  • Oldenburg CE, Acharya NR, Tu EY et al. Practice patterns and opinions in the treatment of acanthamoeba keratitis. Cornea 2011; 30: 1363–1368.
  • Stern GA, Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology 1991; 98: 847–853.
  • Cardenas ME, Cruz MC, Del poeta M et al. Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. Clin Microbiol Rev 1999; 12: 583–611.
  • Perry HD, Doshi SJ, Donnenfeld ED et al. Topical cyclosporin A in the management of therapeutic keratoplasty for mycotic keratitis. Cornea 2002; 21: 161–163.
  • Ansari Z, Miller D, Galor A. Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep 2013; 3: 209–218.
  • Robaei D, Carnt N, Minassian DC et al. Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature. Ophthalmology 2015; 122: 17–24.
  • Villani E, Galimberti D, Viola F et al. In vivo confocal microscopy of the ocular surface. Am J Ophthalmol 2010; 149: 689–690.
  • Sambursky R, Tauber S, Schirra F et al. The RPS adeno detector for diagnosing adenoviral conjunctivitis. Ophthalmology 2006; 113: 1758–1764.
  • Verma MS, Chen PZ, Jones L et al. ‘Chemical nose’ for the visual identification of emerging ocular pathogens using gold nanostars. Biosens Bioelectron 2014; 61: 386–390.
  • Iseli HP, Thiel MA, Hafezi F et al. Ultraviolet A/riboflavin corneal cross‐linking for infectious keratitis associated with corneal melts. Cornea 2008; 27: 590–594.
  • Tayapad JB, Viguilla AQ, Reyes JM. Collagen cross‐linking and corneal infections. Curr Opin Ophthalmol 2013; 24: 288–290.
  • Achouri D, Alhanout K, Piccerelle P et al. Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2013; 39: 1599–1617.
  • Duxfield L, Sultana R, Wang R et al. Ocular delivery systems for topical application of anti‐infective agents. Drug Dev Ind Pharm 2016; 42: 1–11.
  • Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Invest Ophthalmol Vis Sci 2004; 45: 2342–2347.
  • Alvarez‐lorenzo C, Yanez F, Barreiro‐iglesias R et al. Imprinted soft contact lenses as norfloxacin delivery systems. J Controlled Release 2006; 113: 236–244.
  • Garhwal R, Shady SF, Ellis EJ et al. Sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials. Invest Ophthalmol Vis Sci 2012; 53: 1341–1352.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.